ATRACTYLODES

Most people think reflux is caused by “too much acid,” but one of the biggest drivers is actually delayed stomach emptying.
When the stomach holds onto food too long, pressure builds.
Pressure pushes stomach contents upward.
And that pressure also makes the LES — the valve between the stomach and esophagus — relax when it shouldn’t (3–6). 

Atractylodes supports these upstream issues by: 

✔ helping the stomach move food forward
✔ reducing internal pressure
✔ supporting a healthier LES response
✔ calming irritation in the upper GI 

These are foundational functions that PPIs, antacids and barrier-forming products do not address. 

This is why Atractylodes was selected as one of the four targeted botanicals in Re:Flux. 

How Atractylodes Helps With Reflux  

1. Helps your stomach move food forward 

Atractylodes naturally supports healthy stomach contractions so food moves the way it’s supposed to. 

2. Helps reduce pressure that pushes acid upward 

Better movement means less buildup and less pressure — one of the biggest causes of reflux. 

3. Helps the LES (lower esophageal sphincter) work more reliably 

When pressure decreases, the LES relaxes less often, helping keep acid where it belongs. 

4. Helps calm an irritated upper GI 

Atractylodes has gentle anti-inflammatory effects that support stomach comfort. 

5. Works with the other ingredients to support overall digestive flow 

Atractylodes focuses on movement and pressure, while Noni and Dandelion support rhythm and bile flow. 

NERD OUT:  

The Science Behind Atractylodes 

For clinicians, researchers and the science curious, here is the deeper physiology behind Atractylodes’ effects. 

1. Prokinetic Activity (Direct Effects on Gastric Motility) 

Bioactive compounds in Atractylodes — especially atractylenolides — have been shown to: 

• increase gastric contraction amplitude
• enhance rhythmic gastric waves
• promote coordinated forward movement (1,2) 

This directly supports gastric emptying and reduces the intragastric pressure linked to reflux. 

2. Effects on Cholinergic Tone (LES Behavior) 

LES contraction is strongly regulated by acetylcholine-mediated cholinergic tone. 

Low tone → weak LES closure → more reflux episodes (6). 

Atractylodes appears to support cholinergic signaling, promoting: 

• improved LES responsiveness
• fewer transient LES relaxations
• better overall valve behavior 

This mechanism helps reinforce the barrier against upward movement without tightening the LES excessively. 

3. Pressure Modulation 

Improved motility = less stagnation = less pressure. 

Since gastric pressure is a primary trigger for reflux events (3–6), reducing pressure helps restore normal LES behavior and reduces upward flow. 

4. Anti-Inflammatory Pathways 

Atractylenolides have been shown to: 

• inhibit NF-κB activation
• reduce pro-inflammatory cytokines
• support mucosal immune balance (7–9) 

This is relevant because many patients experience esophageal hypersensitivity, not just excess acid (10–11).
Reducing inflammatory signaling lowers the intensity of reflux sensations. 

5. Supports Digestive Calm Without Acid Suppression 

Unlike PPIs or antacids, Atractylodes does not interfere with acid production.
Instead, it improves the mechanics that determine whether acid stays where it belongs. 

Summary 

Atractylodes helps support reflux relief by: 

✔ promoting healthy gastric motility and forward movement
✔ reducing intragastric pressure that triggers reflux events
✔ supporting cholinergic tone for more reliable LES closure
✔ calming upper-GI irritation through anti-inflammatory activity
✔ keeping acid where it belongs without suppressing digestion 

It works by restoring the mechanics of digestion:  Helping the stomach move, empty and function the way it was meant to. 

References: 

1. Zhang RX, Li MX, Jia ZP. Atractylodes macrocephala: pharmacological and clinical research. Phytother Res. 2012;26(10):1521–1527. 
2. Zhou JY, Zhou SW. Effects of atractylenolide on gastrointestinal motility in animal models. Chin J Integr Med. 2010;16(2):126–131. 
3. Chial HJ, Camilleri M, Burton D, Thomforde GM, et al. Gastric motor dysfunction in patients with nonulcer dyspepsia. Am J Gastroenterol. 2003;98(4):775–780. 
4. Parkman HP, Hasler WL, Fisher RS. AGA technical review: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127(5):1689–1710. 
5. Jones MP. Gastric emptying: understanding clinical relevance. Neurogastroenterol Motil. 2006;18(2):106–112. 
6. Dodds WJ, Dent J, Hogan WJ, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. J Clin Invest. 1982;70(2):387–395. 
7. Liu H, Wang J, Zhang C, et al. Anti-inflammatory effects of atractylenolide I via NF-κB pathway modulation. Int Immunopharmacol. 2015;29(2):370–376. 
8. Wang Q, Wu L, Li H, et al. Immunomodulatory effects of Atractylodes macrocephala polysaccharides. J Ethnopharmacol. 2014;152(1):147–155. 
9. Zhao XY, Sun Y, Zhang X. Atractylodes macrocephala and gastrointestinal function: a review of modern pharmacology. J Tradit Chin Med. 2016;36(1):8–13. 
10. Kandulski A, Weigt J, Caro C, et al. Esophageal mucosal injury despite normalized acid exposure in GERD. Am J Gastroenterol. 2012;107(7):1022–1030. 
11. Yadlapati R, Kahrilas PJ. The acid pocket and reflux pathophysiology. Gastroenterology. 2018;154(2):340–351.